LYSINE DEMETHYLASE INHIBITORS FOR INFLAMMATORY DISEASES OR CONDITIONS
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to methods and compositions for the treatment or prevention of inflammation and inflammatory diseases or conditions. In particular, the invention relates to an LSD1 inhibitor, such as a 2-cyclylcylopropan-1-amine derivative, a phenelzine derivative and a propargylamine derivative, for use in treating or preventing inflammation and inflammatory diseases or conditions.
-
Citations
70 Claims
-
1-4. -4. (canceled)
- 5. A method of treating or preventing inflammation or an inflammatory disease or condition, comprising administering to an individual a therapeutically effective amount of a LSD1 inhibitor.
-
6. A method of treating or preventing a symptom of inflammation or an inflammatory disease or condition, comprising administering to an individual a therapeutically effective amount of a LSD1 inhibitor.
-
8-12. -12. (canceled)
-
15. (canceled)
-
19-20. -20. (canceled)
-
24. (canceled)
-
26-34. -34. (canceled)
-
36-37. -37. (canceled)
-
40-42. -42. (canceled)
-
44-50. -50. (canceled)
-
53-60. -60. (canceled)
-
62-68. -68. (canceled)
-
70-71. -71. (canceled)
Specification